Cite
HARVARD Citation
Hannawi, S. et al. (2023). Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial. Journal of infection. 86 (2), pp. 154-225. [Online].